LYVALITY Trademark

Trademark Overview

On Tuesday, October 23, 2018, a trademark application was filed for LYVALITY with the United States Patent and Trademark Office. The USPTO has given the LYVALITY trademark a serial number of 88166120. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 27, 2022. This trademark is owned by Intercept Pharmaceuticals, Inc.. The LYVALITY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, therapeutic bile acid analogues; pharmaceutical preparations for the treatment of liver diseases, disorders and conditions; pharmaceuticals for treating nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, liver fibrosis, and liver cirrhosis
lyvality

General Information

Serial Number88166120
Word MarkLYVALITY
Filing DateTuesday, October 23, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 27, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 26, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, therapeutic bile acid analogues; pharmaceutical preparations for the treatment of liver diseases, disorders and conditions; pharmaceuticals for treating nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, liver fibrosis, and liver cirrhosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 5, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIntercept Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMorristown, NJ 07960
Party NameIntercept Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10001

Trademark Events

Event DateEvent Description
Monday, June 27, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 27, 2022ABANDONMENT - NO USE STATEMENT FILED
Monday, March 21, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 21, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 21, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 21, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 21, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 24, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 23, 2021SOU EXTENSION 5 GRANTED
Wednesday, November 17, 2021SOU EXTENSION 5 FILED
Tuesday, November 23, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 17, 2021SOU TEAS EXTENSION RECEIVED
Thursday, July 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 27, 2021SOU EXTENSION 4 GRANTED
Tuesday, April 27, 2021SOU EXTENSION 4 FILED
Tuesday, April 27, 2021SOU TEAS EXTENSION RECEIVED
Thursday, November 12, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 10, 2020SOU EXTENSION 3 GRANTED
Tuesday, November 10, 2020SOU EXTENSION 3 FILED
Tuesday, November 10, 2020SOU TEAS EXTENSION RECEIVED
Thursday, March 26, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 24, 2020SOU EXTENSION 2 GRANTED
Tuesday, March 24, 2020SOU EXTENSION 2 FILED
Tuesday, March 24, 2020SOU TEAS EXTENSION RECEIVED
Friday, November 15, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 13, 2019SOU EXTENSION 1 GRANTED
Wednesday, November 13, 2019SOU EXTENSION 1 FILED
Wednesday, November 13, 2019SOU TEAS EXTENSION RECEIVED
Monday, November 11, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 11, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 21, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, March 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, February 15, 2019ASSIGNED TO LIE
Thursday, January 31, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 31, 2019EXAMINER'S AMENDMENT ENTERED
Thursday, January 31, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 31, 2019EXAMINERS AMENDMENT E-MAILED
Thursday, January 31, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, January 30, 2019ASSIGNED TO EXAMINER
Monday, November 5, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 26, 2018NEW APPLICATION ENTERED

Related Keywords

lyvality liver pharmaceutical preparations nonalcoholic treating steatohepatitis fatty cirrhosis fibrosis disease